Papp et al. (2025) “CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery” Molecular Therapy.
DOI: 10.1016/j.ymthe.2025.03.018
Read about Papp et al. (2025) “CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery” Molecular Therapy.
PUBLICATION ALERT: Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection
Read about PUBLICATION ALERT: Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection
Broomfield et al. (2025) “Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection” Journal of Experimental Medicine.
DOI: 10.1084/jem.20241148
Read about Broomfield et al. (2025) “Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection” Journal of Experimental Medicine.
PUBLICATION ALERT: Monitoring mRNA vaccine antigen expression in vivo using PET/CT
Read about PUBLICATION ALERT: Monitoring mRNA vaccine antigen expression in vivo using PET/CT
Blizard et al. (2025) “Monitoring mRNA vaccine antigen expression in vivo using PET/CT” Nature Communications.
DOI: 10.1038/s41467-025-57446-w
Read about Blizard et al. (2025) “Monitoring mRNA vaccine antigen expression in vivo using PET/CT” Nature Communications.
PUBLICATION ALERT: iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA
Read about PUBLICATION ALERT: iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA
Yanik et al. (2025) “iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA” NPJ Vaccines.
DOI: 10.1038/s41541-025-01089-x
Read about Yanik et al. (2025) “iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA” NPJ Vaccines.
Acuitas Therapeutics’ Chief Legal Officer Miranda Lam Appointed as King’s Counsel
Read about Acuitas Therapeutics’ Chief Legal Officer Miranda Lam Appointed as King’s Counsel
Dr. Ghania Chikh Named Senior Director, Vaccine Development at Acuitas Therapeutics
Read about Dr. Ghania Chikh Named Senior Director, Vaccine Development at Acuitas Therapeutics
Acuitas Therapeutics’ President & CEO Named a National Winner in the EY Canadian Entrepreneur of the Year Program
Read about Acuitas Therapeutics’ President & CEO Named a National Winner in the EY Canadian Entrepreneur of the Year Program